MUMBAI, India, NAPLES, Fla, May 18, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United States Food a… For the full story, visit the source.
BusinessMaharashtra
Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
MUMBAI, India, NAPLES, Fla, May 18, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United States Food a…
PRNewswire· 5 months ago· 2 min read
This summary is sourced from PRNewswire. Read the full article at:PRNewswire